Lindahl legal advisor to Sedana Medical AB (publ) in connection with a change of listing to Nasdaq Stockholm
Lindahl has acted as a legal advisor to Sedana Medical AB (publ) in connection with the company’s change of listing from Nasdaq First North Growth Market to the Nasdaq Stockholm main list.
Trading in the company’s shares commenced on 25 January 2023. The closing price for the company’s share on the first trading day was SEK 27.06 per share, equivalent to a value of approximately SEK 2.7 billion for all shares in Sedana Medical.
Sedana Medical is a medical technology and pharmaceutical company founded in 2004. The company is based in Danderyd, outside Stockholm, and its operations include development, marketing and sale of the medical device Sedaconda ACD and its accessories, as well as the Sedaconda (isoflurane) sedation medication.
Lindahl’s team consisted mainly of Ola Svanberg, Monica Lagercrantz, Mikael Nagy and Ebba Meyer-Lie (capital markets and public M&A), Mårten Lindberg and Asta Schulz (IP/Tech), Matilda Jusslin (employment) and Anna Romell Stenmark (tax).
Carousel items
-
Cases and transactions
4/3/2025
Lindahl advises Alder in connection with investment in 3Button Group AB
Lindahl has advised Alder in connection with its investment in 3Button Group AB, a leading provider of advanced industrial automation solutions.
-
Knowledge
3/27/2025
Termination Due to Poor Work Performance – How to Act Correctly as an Employer
As an employer, it can be challenging to know how to handle an employee who is not performing as expected and when it is serious enough to justify termination. The so-called LAS reform of 2022, where the term "objective grounds" was replaced with...
-
News articles
3/26/2025
Lindahl ranked in The Legal 500
Lindahl is proud to be ranked in The Legal 500 2025, with outstanding reviews and recognitions both for the firm as a whole and for our individually ranked lawyers.
-
Read more news and insights?